Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vaccinia
Phenotype C0025202|melanoma
Sentences 2
PubMedID- 24829758 We have identified ilt2 as a potential biomarker of clinical response in melanoma patients treated with oncolytic vaccinia virus immunotherapy.
PubMedID- 23833682 The uniqueness of our immunotherapeutic vaccine arises from infecting primary melanoma cells with live vaccinia virus, which acts as a natural adjuvant.

Page: 1